The Need for More Accurate and Timely Diagnosis in Fanconi Anemia: A Report From the International Fanconi Anemia Registry
1 From the Division of Human Genetics, New York, NY.
2 From The Rockefeller University, New York, NY.
3 From the Division of Pediatric Neurology, New York Hospital-Cornell University Medical College, New York, NY.
Objective. The objective of this study was to address the need for early diagnosis of Fanconi anemia (FA), an autosomal recessive chromosomal instability syndrome characterized by a unique cellular hypersensitivity to DNA cross-linking agents, such as diepoxybutane, and by a high risk of malignancies.
Methods. We analyzed data from 370 FA patients enrolled in the American Registry of the International FA Registry. Of these individuals, 220 had congenital malformations; the rest were ascertained based on hematologic abnormalities only or on clinical evaluation and screening following the diagnosis of an affected family member. The probands noted to have congenital malformations at the time of diagnosis were classified into two groups on the basis of their clinical presentation: (1) patients manifesting both congenital malformations and hematologic abnormalities (159 individuals); (2) patients manifesting congenital malformations only (61 individuals).
Results. The mean age of diagnosis was 6.6 years and 1.1 years for Groups 1 and 2, respectively. Thus, the majority of FA patients with congenital malformations were not diagnosed until after the onset of hematologic abnormalities. We also report central nervous system, gastrointestinal, and skeletal malformations which previously have not been included as part of the FA phenotype. Our review of the patients enrolled in the International FA Registry indicates that the FA phenotype is more variable than recognized previously.
Conclusions. Testing for sensitivity to diepoxybutane to rule out a diagnosis of FA needs to be applied more widely in patients with congenital malformations. All siblings of affected probands also should have testing, because a lack of concordance of phenotype in affected siblings makes clinical diagnosis unreliable even within sibships. A more timely diagnosis of FA in the preanemic phase is needed to implement appropriate therapy and to enable parents to make informed reproductive decisions.
Key Words: Fanconi anemia • congenital abnormalities • central nervous system • gastrointestinal system • skeletal malformations • hematologic abnormalities
Submitted on September 17, 1992
Accepted on January 5, 1993
This article has been cited by other articles:
 |
|
 |
|
  E. C. Guinan Aplastic Anemia: Management of Pediatric Patients Hematology, January 1, 2005; 2005(1): 104 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Offit, O. Levran, B. Mullaney, K. Mah, K. Nafa, S. D. Batish, R. Diotti, H. Schneider, A. Deffenbaugh, T. Scholl, et al. Shared Genetic Susceptibility to Breast Cancer, Brain Tumors, and Fanconi Anemia J Natl Cancer Inst, October 15, 2003; 95(20): 1548 - 1551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. I. Kutler, B. Singh, J. Satagopan, S. D. Batish, M. Berwick, P. F. Giampietro, H. Hanenberg, and A. D. Auerbach A 20-year perspective on the International Fanconi Anemia Registry (IFAR) Blood, February 15, 2003; 101(4): 1249 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. I. Kutler, A. D. Auerbach, J. Satagopan, P. F. Giampietro, S. D. Batish, A. G. Huvos, A. Goberdhan, J. P. Shah, and B. Singh High Incidence of Head and Neck Squamous Cell Carcinoma in Patients With Fanconi Anemia Arch Otolaryngol Head Neck Surg, January 1, 2003; 129(1): 106 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Shimamura, R. M. de Oca, J. L. Svenson, N. Haining, L. A. Moreau, D. G. Nathan, and A. D. D'Andrea A novel diagnostic screen for defects in the Fanconi anemia pathway Blood, December 15, 2002; 100(13): 4649 - 4654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K L Greenhalgh, R T Howell, A Bottani, P J Ancliff, H G Brunner, C C Verschuuren-Bemelmans, E Vernon, K W Brown, and R A Newbury-Ecob Thrombocytopenia-absent radius syndrome: a clinical genetic study J. Med. Genet., December 1, 2002; 39(12): 876 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. D'Andrea, N. Dahl, E. C. Guinan, and A. Shimamura Marrow Failure Hematology, January 1, 2002; 2002(1): 58 - 72. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. P. Wajnrajch, J. M. Gertner, Z. Huma, J. Popovic, K. Lin, P. C. Verlander, S. D. Batish, P. F. Giampietro, J. G. Davis, M. I. New, et al. Evaluation of Growth and Hormonal Status in Patients Referred to the International Fanconi Anemia Registry Pediatrics, April 1, 2001; 107(4): 744 - 754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Faivre, P. Guardiola, C. Lewis, I. Dokal, W. Ebell, A. Zatterale, C. Altay, J. Poole, D. Stones, M. L. Kwee, et al. Association of complementation group and mutation type with clinical outcome in Fanconi anemia Blood, December 15, 2000; 96(13): 4064 - 4070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Cassinat, P. Guardiola, S. Chevret, M.-H. Schlageter, M.-E. Toubert, J.-D. Rain, and E. Gluckman Constitutive elevation of serum alpha-fetoprotein in Fanconi anemia Blood, August 1, 2000; 96(3): 859 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Haneline, T. A. Gobbett, R. Ramani, M. Carreau, M. Buchwald, M. C. Yoder, and D. W. Clapp Loss of FancC Function Results in Decreased Hematopoietic Stem Cell Repopulating Ability Blood, July 1, 1999; 94(1): 1 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M Powell and R. C Michaelis Townes-Brocks syndrome J. Med. Genet., February 1, 1999; 36(2): 89 - 93. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y Perel, O Butenandt, A Carrere, R Saura, M Fayon, T Lamireau, and P Vergnes Oesophageal atresia, VACTERL association: Fanconi's anaemia related spectrum of anomalies Arch. Dis. Child., April 1, 1998; 78(4): 375 - 376. [Abstract] [Full Text]
|
|
|
|
 |
|
 O. Levran, T. Erlich, N. Magdalena, J. J. Gregory, S. D. Batish, P. C. Verlander, and A. D. Auerbach Sequence variation in the Fanconi anemia gene FAA PNAS, November 25, 1997; 94(24): 13051 - 13056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. D'Andrea and M. Grompe Molecular Biology of Fanconi Anemia: Implications for Diagnosis and Therapy Blood, September 1, 1997; 90(5): 1725 - 1736. [Full Text] [PDF]
|
|
|
|
|
|
A. P. Gillio, P. C. Verlander, S.D. Batish, P.F. Giampietro, and A. D. Auerbach Phenotypic Consequences of Mutations in the Fanconi Anemia FAC Gene: An International Fanconi Anemia Registry Study Blood, July 1, 1997; 90(1): 105 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Youssoufian, A. D. Auerbach, P. C. Verlander, V. Steimle, and B. Mach Identification of Cytosolic Proteins That Bind to the Fanconi Anemia Complementation Group C Polypeptide in Vitro J. Biol. Chem., April 28, 1995; 270(17): 9876 - 9882. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Giampietro, J. G. Davis, and A. D. Auerbach Fanconi's Anemia N. Engl. J. Med., March 10, 1994; 330(10): 720 - 721. [Full Text]
|
|
